[Chronic graft-versus-host disease presenting as nephrotic syndrome after allogenic hematopoietic stem cell

Janina Priluckiene1, Indre Kriukelyte, Mindaugas Jurgutis

  • 1Department of Nephrology and Dialysis, Seamen's Hospital of Klaipeda, Klaipeda, Lithuania. nefrologija@junet.lt

Insights

Chronic graft-versus-host disease, a late complication of allogeneic stem cell transplant, can affect kidneys, presenting as nephrotic syndrome. This case highlights kidney biopsy findings and successful treatment with immunosuppressants.

Area of Science:

  • Nephrology
  • Hematology
  • Immunology

Background:

  • Allogeneic hematopoietic stem cell transplantation (HSCT) can lead to early (<100 days) and late (>100 days) complications.
  • Chronic graft-versus-host disease (cGVHD) is a frequent late complication (60-80% of survivors), primarily affecting skin, mucous membranes, GI tract, and liver.
  • Kidneys are not typically considered a target organ for cGVHD, though renal involvement has been reported.

Observation:

  • A patient developed nephrotic syndrome three years after HSCT.
  • Kidney biopsy revealed membranous nephropathy as the cause of nephrotic syndrome.
  • This presentation suggests a potential manifestation of cGVHD in the kidneys.

Findings:

  • The patient's nephrotic syndrome was attributed to membranous nephropathy.
  • Treatment with cyclosporine and methylprednisolone resulted in a significant reduction in albuminuria.
  • This indicates a positive response to immunosuppressive therapy.

Implications:

  • This case expands the understanding of potential cGVHD target organs beyond traditional sites.
  • It emphasizes the importance of considering cGVHD in patients with unexplained nephrotic syndrome post-HSCT.
  • Early diagnosis and treatment of renal cGVHD may improve patient outcomes and reduce morbidity.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview